Literature DB >> 33758035

Evaluations of SARS-CoV-2 Serological Assay Performance Need Inclusion of Long-Term Samples.

Julien Favresse1,2, Jonathan Douxfils2,3.   

Abstract

Entities:  

Keywords:  COVID-19; SARS-CoV-2; anti-NCP antibodies; anti-S antibodies

Year:  2021        PMID： 33758035     DOI： 10.1128/JCM.00487-21

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  3 in total

1.  SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada: a cross-sectional study.

Authors:  David M Goldfarb; Louise C Mâsse; Allison W Watts; Sarah M Hutchison; Lauren Muttucomaroe; Else S Bosman; Vilte E Barakauskas; Alexandra Choi; Nalin Dhillon; Michael A Irvine; Frederic Reicherz; Collette O'Reilly; Sadaf Sediqi; Rui Yang Xu; Hamid R Razzaghian; Manish Sadarangani; Daniel Coombs; Sheila F O'Brien; Pascal M Lavoie
Journal:  BMJ Open       Date:  2022-04-05       Impact factor: 2.692

2.  Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity.

Authors:  Julien Favresse; Jean-Louis Bayart; Clara David; Constant Gillot; Grégoire Wieërs; Gatien Roussel; Guillaume Sondag; Marc Elsen; Christine Eucher; Jean-Michel Dogné; Jonathan Douxfils
Journal:  Viruses       Date:  2022-07-28       Impact factor: 5.818

3.  Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2.

Authors:  Julien Favresse; Constant Gillot; Laura Di Chiaro; Christine Eucher; Marc Elsen; Sandrine Van Eeckhoudt; Clara David; Laure Morimont; Jean-Michel Dogné; Jonathan Douxfils
Journal:  Viruses       Date:  2021-07-14       Impact factor: 5.048
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.